US FDA puts clinical hold on Kezar Life Sciences’ lupus treatment trial
News | October 4, 2024
FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland
(Reuters) – The U.S. Food and Drug Administration has placed a clinical hold on Kezar Life Sciences’ trial of experimental drug for lupus, the company said on Friday.
(Reporting by Mariam Sunny in Bengaluru; Editing by Mohammed Safi Shamsi)